BIO-key Intl (NASDAQ:BKYI) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.80) by 81.25 percent. This is a 90.45 percent increase over losses of $(1.57) per share from the same period last year. The company reported quarterly sales of $2.146 million which missed the analyst consensus estimate of $2.200 million by 2.45 percent. This is a 26.46 percent increase over sales of $1.697 million the same period last year.